Synthesis, characterization and in vitro biological evaluation of some new 1,3,5-triazine-bis-azomethine hybrid molecules as potential antitubercular agents
Open Access
- 30 June 2014
- journal article
- Published by European Journal of Chemistry in European Journal of Chemistry
- Vol. 5 (2), 374-379
- https://doi.org/10.5155/eurjchem.5.2.374-379.1027
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial, antimycobacterial and anticancer agentsEuropean Journal of Medicinal Chemistry, 2011
- Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand–receptor recognition processBioorganic & Medicinal Chemistry, 2010
- Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivativesBioorganic & Medicinal Chemistry, 2009
- Synthesis of 2,4,6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agentsBioorganic & Medicinal Chemistry, 2006
- Recent applications of 2,4,6-trichloro-1,3,5-triazine and its derivatives in organic synthesisTetrahedron, 2006
- Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductaseProceedings of the National Academy of Sciences of the United States of America, 1997
- Hexamethylmelamine: A critical review of an active drugCancer Treatment Reviews, 1986
- Structure-activity relationships of dihydrofolated reductase inhibitorsChemical Reviews, 1984
- Inhibition of dihydrofolate reductase. 3. 4,6-Diamino-1,2-dihydro-2,2-dimethyl-1-(2-substituted-phenyl)-s-triazine inhibition of bovine liver and mouse tumor enzymesJournal of Medicinal Chemistry, 1980
- Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazineJournal of Medicinal Chemistry, 1973